Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria.
Zeynep KeskinkayaÖzge KayaSelda Işık MermutluZerrin Öğretmen
Published in: International archives of allergy and immunology (2024)
Omalizumab is an effective and safe treatment in CSU. The IgG anti-TPO/total IgE ratio seems a valuable tool to predict the early and late responders, the former having a higher possibility of relapse upon drug withdrawal.